PHAT earnings
Phathom Pharmaceuticals (PHAT) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
PHAT earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | -0.16 | -0.11 | -45.85% | $84.72M |
| Q2 2026 | Jul 30, 2026 | -0.21 | -0.18 | -19.60% | $74.27M |
| Q1 2026 | Apr 30, 2026 | -0.37 | -0.27 | -37.04% | $58.30M |
| Q4 2025 | Feb 26, 2026 | -0.29 | -0.32 | 9.18% | $57.58M |
| Q3 2025 | Oct 30, 2025 | -0.41 | -0.40 | -2.50% | $49.50M |
| Q2 2025 | Aug 7, 2025 | -0.79 | -0.76 | -3.95% | $39.50M |
| Q1 2025 | May 1, 2025 | -1.07 | -1.06 | -0.94% | $28.52M |
| Q4 2024 | Mar 6, 2025 | -0.79 | -1.29 | 38.76% | $29.66M |
| Q3 2024 | Nov 7, 2024 | -1.32 | -1.57 | 15.92% | $16.35M |
| Q2 2024 | Aug 8, 2024 | -1.25 | -1.20 | -4.17% | $7.32M |
| Q1 2024 | May 9, 2024 | -1.42 | -1.43 | 0.70% | $1.91M |
| Q4 2023 | Mar 6, 2024 | -1.39 | -1.08 | -29.05% | $682.00K |
| Nov 9, 2023 | -0.76 | -0.95 | 20.00% | – | |
| Aug 10, 2023 | -0.84 | -0.95 | 11.58% | – | |
| May 10, 2023 | -0.89 | -1.34 | 33.58% | – | |
| Feb 28, 2023 | -1.33 | -1.50 | 11.33% | – | |
| Nov 8, 2022 | -1.32 | -1.32 | 0.00% | – | |
| Aug 2, 2022 | -1.33 | -1.03 | -29.13% | – | |
| May 10, 2022 | -1.07 | -0.97 | -10.31% | – | |
| Mar 1, 2022 | -0.95 | -0.86 | -10.47% | – |
- PHAT beat EPS estimates in 11 of its last 29 reports.
Updated 2026-11-03 04:20 UTC